Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis?

Critical Care Medicine

Volumn 31, Issue 3, 2003, Pages 752-757

  Dupont, Hervé ^a   Bourichon, Agnes ^a   Paugam Burtz, Catherine ^a   Mantz, Jean ^a   Desmonts, Jean Marie ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Candida; Intensive care; Peritonitis; Risk factors; Score

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; GENTAMICIN; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FUNGUS ISOLATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEART FAILURE; HUMAN; INTENSIVE CARE UNIT; INTRAOPERATIVE PERIOD; MALE; PERITONEAL FLUID; PERITONITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; SURGICAL PATIENT; UNIVERSITY HOSPITAL; VALIDATION PROCESS; YEAST;

AGED; ANTI-BACTERIAL AGENTS; ASCITIC FLUID; BACTERIAL INFECTIONS; CANDIDA; CANDIDIASIS; CROSS INFECTION; FEMALE; HOSPITAL MORTALITY; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PERITONITIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0037351577     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000053525.49267.77     Document Type: Article

References (40)

1. Montravers P, Gauzit R, Muller C, et al: Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis 1996; 23:486-494
2. Mosdell DM, Morris DM, Voltura A, et al: Antibiotic treatment for surgical peritonitis. Ann Surg 1991; 214:543-549
3. Roehrborn A, Thomas L, Potreck O, et al: The microbiology of postoperative peritonitis. Clin Infect Dis 2001; 33:1513-1519
4. Nathens AB, Rotstein OD, Marshall JC: Tertiary peritonitis: Clinical features of a complex nosocomial infection. World J Surg 1998; 22:158-163
5. Solomkin JS, Flohr AB, Quie PG, et al: The role of Candida in intraperitoneal infections. Surgery 1980; 88:524-530
6. Vincent JL, Bihari DJ, Suter PM, et al: The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274:639-644
7. Edwards JE, Bodey GP, Bowden RA, et al: International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis 1997; 25:43-59
8. Rex JH, Walsh TJ, Sobel JD, et al: Practice guidelines for the treatment of candidiasis. Clin Infect Dis 2000; 30:662-678
9. Pittet D, Monod M, Suter PM, et al: Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994; 220:751-758
10. Wenzel RP: Nosocomial candidemia: Risk factors and attributable mortality. Clin Infect Dis 1995; 20:1531-1534
11. Bosscha K, van Vroonhoven TJ, van der Werken C: Surgical management of severe secondary peritonitis. Br J Surg 1999; 86:1371-1377
12. Paugam-Burtz C, Dupont H, Marmuse JP, et al: Daily organ-system failure for diagnosis of persistent intra-abdominal sepsis after postoperative peritonitis. Intensive Care Med 2002; 28:594-598
13. Soussy CJ, Carret G, Cavallo JD, et al: Anti-biogram Committee of the French Microbiology Society. Report 2000-2001. Pathol Biol (Paris) 2000; 48:832-871
14. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-829
15. Le Gall JR, Lemeshow S, Saulnier F: A new simplified acute physiology score (SAPS II) based on a European-North American multicenter study. JAMA 1993; 270:29057-29068
16. Knaus WA, Draper EA, Wagner DP, et al: Prognosis in acute organ-system failure. Ann Surg 1985; 202:685-693
17. McCabe WR, Jackson GG: Gram negative bacteremia, etiology and ecology. Arch Intern Med 1962; 110:845
18. Fagon JY, Chastre J, Novara A, et al: Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunction and/or infection. Intensive Care Med 1993; 19:137-144
19. Goldie SJ, Kiernan Tridle L, Torres C, et al: Fungal peritonitis in a large chronic peritoneal dialysis population: A report of 55 episodes. Am J Kidney Dis 1996; 28:86-91
20. Eleftheriadis E, Kotzampassi K, Papanotas K, et al: Gut ischemia, oxidative stress, and bacterial translocation in elevated abdominal pressure in rats. World J Surg 1996; 20:11-16
21. Gianotti L, Alexander JW, Fukushima R, et al: Translocation of Candida albicans is related to the blood flow of individual intestinal villi. Circ Shock 1993; 40:250-257
22. Sawyer RG, Adams RB, May AK, et al: Development of Candida albicans and C. albicans/Escherichia coli/Bacteroides fragilis intraperitoneal abscess models with demonstration of fungus-induced bacterial translocation. J Med Vet Mycol 1995; 33:49-52
23. Hennequin C: Endogenous candidal peritonitis. J Mycol Med 2000; 10:21-26
24. Peoples JB: Candida and perforated peptic ulcers. Surgery 1986; 100:758-764
25. Calandra T, Bille J, Schneider R, et al: Clinical significance of Candida isolated from peritoneum in surgical patients. Lancet 1989; 2:1437-1440
26. Bayer AS, Blumenkrantz MJ, Montgomerie JZ, et al: Candida peritonitis. Report of 22 cases and review of the English literature. Am J Med 1976; 61:832-840
27. Alden SM, Frank E, Flancbaum L: Abdominal candidiasis in surgical patients. Am Surg 1989; 55:45-49
28. Diebel LN, Raafat AM, Dulchavsky SA, et al: Gallbladder and biliary tract candidiasis. Surgery 1996; 120:760-764
29. Morris AB, Sands ML, Shiraki M, et al: Gallbladder and biliary tract candidiasis: Nine cases and review. Rev Infect Dis 1990; 12:483-489
30. Solomkin JS, Flohr AM, Simmons RL: Indications for therapy for fungemia in postoperative patients. Arch Surg 1982; 117:1272-1275
31. Mikamo H, Sato Y, Hayasaki Y, et al: Current status and fluconazole treatment of pelvic fungal gynecological infections. Chemotherapy 2000; 46:209-212
32. Vincent JL, Anaissie E, Bruining H, et al: Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 1998; 24:206-216
33. Marsh PK, Tally FP, Kellum J, et al: Candida infections in surgical patients. Ann Surg 1983; 198:42-47
34. Knoke M: Gastrointestinal microecology of humans and Candida. Mycoses 1999; 42:30-34
35. McLauchlan GJ, Anderson ID, Grant IS, et al: Outcome of patients with intraabdominal sepsis treated in an intensive care unit. Br J Surg 1995; 82:524-529
36. Dupont H, Gauzit R, Montravers P, et al: Pathogenic role of Candida in postoperative peritonitis. 39th Annual Meeting of the Infectious Disease Society of America. San Francisco, 2001, p 77 (abstr 222)
37. Pelz RK, Hendrix CW, Swoboda SM, et al: Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 2001; 233:542-548
38. Burgener-Kairuz P, Zuber JP, Jaunin P, et al: Rapid detection and identification of Candida albicans and Torulopsis (Candida) glabrata in clinical specimens by species-specific nested PCR amplification of a cytochrome P-450 lanosterol-alpha-demethylase (L1A1) gene fragment. J Clin Microbiol 1994; 32:1902-1907
39. Crampin AC, Matthews RC: Application of the polymerase chain reaction to the diagnosis of candidosis by amplification of an HSP 90 gene fragment. J Med Microbiol 1993; 39:233-238
40. Stevens DA: Diagnosis of fungal infections: Current status. J Antimicrob Chemother 2002; 49(Suppl 1):11-19